Tobisawa, Y.; Nakane, K.; Koie, T.; Taniguchi, T.; Tomioka, M.; Tomioka-Inagawa, R.; Kawase, K.; Kawase, M.; Iinuma, K.
Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness. Biomedicines 2025, 13, 682.
https://doi.org/10.3390/biomedicines13030682
AMA Style
Tobisawa Y, Nakane K, Koie T, Taniguchi T, Tomioka M, Tomioka-Inagawa R, Kawase K, Kawase M, Iinuma K.
Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness. Biomedicines. 2025; 13(3):682.
https://doi.org/10.3390/biomedicines13030682
Chicago/Turabian Style
Tobisawa, Yuki, Keita Nakane, Takuya Koie, Tomoki Taniguchi, Masayuki Tomioka, Risa Tomioka-Inagawa, Kota Kawase, Makoto Kawase, and Koji Iinuma.
2025. "Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness" Biomedicines 13, no. 3: 682.
https://doi.org/10.3390/biomedicines13030682
APA Style
Tobisawa, Y., Nakane, K., Koie, T., Taniguchi, T., Tomioka, M., Tomioka-Inagawa, R., Kawase, K., Kawase, M., & Iinuma, K.
(2025). Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness. Biomedicines, 13(3), 682.
https://doi.org/10.3390/biomedicines13030682